Report Detail
Global Phosphodiesterase (PDE) inhibitors Market Insights, Forecast to 2025
- RnM3664876 |
- 13 August, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).
PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period.
The global Phosphodiesterase (PDE) inhibitors market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Phosphodiesterase (PDE) inhibitors market based on company, product type, end user and key regions.
This report studies the global market size of Phosphodiesterase (PDE) inhibitors in key regions like North America, Europe, China and Japan, focuses on the consumption of Phosphodiesterase (PDE) inhibitors in these regions.
This research report categorizes the global Phosphodiesterase (PDE) inhibitors market by top players/brands, region, type and end user. This report also studies the global Phosphodiesterase (PDE) inhibitors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer AG
Eli Lilly and Co.
GlaxoSmithKline Plc
Pfizer Inc.
Vivus Inc.
...
Phosphodiesterase (PDE) inhibitors market size by Type
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors
Phosphodiesterase (PDE) inhibitors market size by Applications
Oral
Topical
Other
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Phosphodiesterase (PDE) inhibitors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Phosphodiesterase (PDE) inhibitors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Phosphodiesterase (PDE) inhibitors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Phosphodiesterase (PDE) inhibitors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Phosphodiesterase (PDE) inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Liter). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Phosphodiesterase (PDE) inhibitors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Phosphodiesterase (PDE) inhibitors Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Phosphodiesterase (PDE) inhibitors Market Size Growth Rate by Type
- 1.4.2 PDE1 Selective Inhibitors
- 1.4.3 PDE2 Selective Inhibitors
- 1.4.4 PDE3 Selective Inhibitors
- 1.4.5 PDE4 selective inhibitors
- 1.4.6 PDE5 selective inhibitors
- 1.4.7 PDE7 selective inhibitors
- 1.4.8 PDE10 selective inhibitors
- 1.5 Market by Application
- 1.5.1 Global Phosphodiesterase (PDE) inhibitors Market Size Growth Rate by Application
- 1.5.2 Oral
- 1.5.3 Topical
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Phosphodiesterase (PDE) inhibitors Market Size
- 2.1.1 Global Phosphodiesterase (PDE) inhibitors Revenue 2014-2025
- 2.1.2 Global Phosphodiesterase (PDE) inhibitors Sales 2014-2025
- 2.2 Phosphodiesterase (PDE) inhibitors Growth Rate by Regions
- 2.2.1 Global Phosphodiesterase (PDE) inhibitors Sales by Regions
- 2.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Phosphodiesterase (PDE) inhibitors Sales by Manufacturers
- 3.1.1 Phosphodiesterase (PDE) inhibitors Sales by Manufacturers
- 3.1.2 Phosphodiesterase (PDE) inhibitors Sales Market Share by Manufacturers
- 3.2 Phosphodiesterase (PDE) inhibitors Revenue by Manufacturers
- 3.2.1 Phosphodiesterase (PDE) inhibitors Revenue by Manufacturers (2014-2019)
- 3.2.2 Phosphodiesterase (PDE) inhibitors Revenue Share by Manufacturers (2014-2019)
- 3.3 Phosphodiesterase (PDE) inhibitors Price by Manufacturers
- 3.4 Phosphodiesterase (PDE) inhibitors Manufacturing Base Distribution, Product Types
- 3.4.1 Phosphodiesterase (PDE) inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Phosphodiesterase (PDE) inhibitors Product Type
- 3.4.3 Date of International Manufacturers Enter into Phosphodiesterase (PDE) inhibitors Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Phosphodiesterase (PDE) inhibitors Sales by Type
- 4.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Type
- 4.3 Phosphodiesterase (PDE) inhibitors Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Phosphodiesterase (PDE) inhibitors Breakdown Data by Application
6 North America
- 6.1 North America Phosphodiesterase (PDE) inhibitors by Country
- 6.1.1 North America Phosphodiesterase (PDE) inhibitors Sales by Country
- 6.1.2 North America Phosphodiesterase (PDE) inhibitors Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Phosphodiesterase (PDE) inhibitors by Type
- 6.3 North America Phosphodiesterase (PDE) inhibitors by Application
7 Europe
- 7.1 Europe Phosphodiesterase (PDE) inhibitors by Country
- 7.1.1 Europe Phosphodiesterase (PDE) inhibitors Sales by Country
- 7.1.2 Europe Phosphodiesterase (PDE) inhibitors Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Phosphodiesterase (PDE) inhibitors by Type
- 7.3 Europe Phosphodiesterase (PDE) inhibitors by Application
8 Asia Pacific
- 8.1 Asia Pacific Phosphodiesterase (PDE) inhibitors by Region
- 8.1.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Region
- 8.1.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
- 8.2 Asia Pacific Phosphodiesterase (PDE) inhibitors by Type
- 8.3 Asia Pacific Phosphodiesterase (PDE) inhibitors by Application
9 Central & South America
- 9.1 Central & South America Phosphodiesterase (PDE) inhibitors by Country
- 9.1.1 Central & South America Phosphodiesterase (PDE) inhibitors Sales by Country
- 9.1.2 Central & South America Phosphodiesterase (PDE) inhibitors Revenue by Country
- 9.1.3 Brazil
- 9.2 Central & South America Phosphodiesterase (PDE) inhibitors by Type
- 9.3 Central & South America Phosphodiesterase (PDE) inhibitors by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors by Country
- 10.1.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country
- 10.1.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors by Type
- 10.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors by Application
11 Company Profiles
- 11.1 Bayer AG
- 11.1.1 Bayer AG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bayer AG Phosphodiesterase (PDE) inhibitors Products Offered
- 11.1.5 Bayer AG Recent Development
- 11.2 Eli Lilly and Co.
- 11.2.1 Eli Lilly and Co. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Products Offered
- 11.2.5 Eli Lilly and Co. Recent Development
- 11.3 GlaxoSmithKline Plc
- 11.3.1 GlaxoSmithKline Plc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Products Offered
- 11.3.5 GlaxoSmithKline Plc Recent Development
- 11.4 Pfizer Inc.
- 11.4.1 Pfizer Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Products Offered
- 11.4.5 Pfizer Inc. Recent Development
- 11.5 Vivus Inc.
- 11.5.1 Vivus Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Products Offered
- 11.5.5 Vivus Inc. Recent Development
12 Future Forecast
- 12.1 Phosphodiesterase (PDE) inhibitors Market Forecast by Regions
- 12.1.1 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Regions 2019-2025
- 12.1.2 Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Regions 2019-2025
- 12.2 Phosphodiesterase (PDE) inhibitors Market Forecast by Type
- 12.2.1 Global Phosphodiesterase (PDE) inhibitors Sales Forecast by Type 2019-2025
- 12.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Forecast by Type 2019-2025
- 12.3 Phosphodiesterase (PDE) inhibitors Market Forecast by Application
- 12.4 North America Phosphodiesterase (PDE) inhibitors Forecast
- 12.5 Europe Phosphodiesterase (PDE) inhibitors Forecast
- 12.6 Asia Pacific Phosphodiesterase (PDE) inhibitors Forecast
- 12.7 Central & South America Phosphodiesterase (PDE) inhibitors Forecast
- 12.8 Middle East and Africa Phosphodiesterase (PDE) inhibitors Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Phosphodiesterase (PDE) inhibitors Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Phosphodiesterase(PDE)inhibitors. Industry analysis & Market Report on Phosphodiesterase(PDE)inhibitors is a syndicated market report, published as Global Phosphodiesterase (PDE) inhibitors Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Phosphodiesterase(PDE)inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
